_id

6915ecdebc934aba376b1dad

Ticker

RCKTW

Name

Rocket Pharmaceuticals, Inc. Warrant

Exchange

NASDAQ

Address

-

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

-

Description

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.

Last Close

0.0304

Volume

7898

Current Price

0.0209

Change

-0.0026

Last Updated

2026-01-06T10:03:48.273Z

Image

-

Ipo Date

2023-02-27T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

52419000

Operating Income

-52419000

Interest Expense

473000

Pretax Income

-50332000

Net Income

-50332000

Eps

-0.4651384455491231

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-

EBITDA

-

Operating Margin

-

Total Other Income Expense Net

172000

Cash

75948000

Short Term Investments

146810000

Receivables

-

Inventories

-

Total Current Assets

227680000

Property Plant Equipment

74169000

Total Assets

368033000

Payables

-

Short Term Debt

-

Long Term Debt

-

Total Liabilities

54364000

Equity

313669000

Bs_currency_symbol

USD

Depreciation

3240000

Change In Working Capital

-11488000

Cash From Operations

-50420000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-67000

Net Change In Cash

43129000

Cf_currency_symbol

USD

PE

-

PB

0.007210022790584979

ROE

-16.04621432146626

ROA

-13.67594753731323

FCF

-50420000

Fcf Percent

-

Piotroski FScore

0

Health Score

41

Deep Value Investing Score

5

Defensive Investing Score

5

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

2

Quality Investing Score

3

Value Investing Score

5.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

52419000

Quarters > 0 > income Statement > operating Income

-52419000

Quarters > 0 > income Statement > interest Expense

473000

Quarters > 0 > income Statement > pretax Income

-50332000

Quarters > 0 > income Statement > net Income

-50332000

Quarters > 0 > income Statement > eps

-0.4651384455491231

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

108208643

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

172000

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

75948000

Quarters > 0 > balance Sheet > short Term Investments

146810000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

227680000

Quarters > 0 > balance Sheet > property Plant Equipment

74169000

Quarters > 0 > balance Sheet > total Assets

368033000

Quarters > 0 > balance Sheet > payables

-

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

54364000

Quarters > 0 > balance Sheet > equity

313669000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-50332000

Quarters > 0 > cash Flow > depreciation

3240000

Quarters > 0 > cash Flow > change In Working Capital

-11488000

Quarters > 0 > cash Flow > cash From Operations

-50420000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-67000

Quarters > 0 > cash Flow > net Change In Cash

43129000

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.4651384455491231

Quarters > 0 > ratios > PB

0.007210022790584979

Quarters > 0 > ratios > ROE

-16.04621432146626

Quarters > 0 > ratios > ROA

-13.67594753731323

Quarters > 0 > ratios > FCF

-50420000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

41

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

67678000

Quarters > 1 > income Statement > operating Income

-67678000

Quarters > 1 > income Statement > interest Expense

473000

Quarters > 1 > income Statement > pretax Income

-68919000

Quarters > 1 > income Statement > net Income

-68919000

Quarters > 1 > income Statement > eps

-0.6388225473149877

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

107884420

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-3471000

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

32819000

Quarters > 1 > balance Sheet > short Term Investments

238675000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

277155000

Quarters > 1 > balance Sheet > property Plant Equipment

77640000

Quarters > 1 > balance Sheet > total Assets

420979000

Quarters > 1 > balance Sheet > payables

-

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

66768000

Quarters > 1 > balance Sheet > equity

354211000

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-68919000

Quarters > 1 > cash Flow > depreciation

2579000

Quarters > 1 > cash Flow > change In Working Capital

8731000

Quarters > 1 > cash Flow > cash From Operations

-48964000

Quarters > 1 > cash Flow > capital Expenditures

50000

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

215000

Quarters > 1 > cash Flow > net Change In Cash

-16988000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.6388225473149877

Quarters > 1 > ratios > PB

0.006365653178472717

Quarters > 1 > ratios > ROE

-19.457046788496122

Quarters > 1 > ratios > ROA

-16.371125400554423

Quarters > 1 > ratios > FCF

-49014000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

64388000

Quarters > 2 > income Statement > operating Income

-64388000

Quarters > 2 > income Statement > interest Expense

472000

Quarters > 2 > income Statement > pretax Income

-61334000

Quarters > 2 > income Statement > net Income

-61334000

Quarters > 2 > income Statement > eps

-0.5745364623073299

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

106753886

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

49810000

Quarters > 2 > balance Sheet > short Term Investments

268354000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

324493000

Quarters > 2 > balance Sheet > property Plant Equipment

80393000

Quarters > 2 > balance Sheet > total Assets

471066000

Quarters > 2 > balance Sheet > payables

-

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

58928000

Quarters > 2 > balance Sheet > equity

412138000

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-61334000

Quarters > 2 > cash Flow > depreciation

2989000

Quarters > 2 > cash Flow > change In Working Capital

-5701000

Quarters > 2 > cash Flow > cash From Operations

-55790000

Quarters > 2 > cash Flow > capital Expenditures

364000

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-113825000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.5745364623073299

Quarters > 2 > ratios > PB

0.005413614414104014

Quarters > 2 > ratios > ROE

-14.881908486963106

Quarters > 2 > ratios > ROA

-13.020256184908272

Quarters > 2 > ratios > FCF

-56154000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

62694000

Quarters > 3 > income Statement > operating Income

-62694000

Quarters > 3 > income Statement > interest Expense

473000

Quarters > 3 > income Statement > pretax Income

-60327000

Quarters > 3 > income Statement > net Income

-60327000

Quarters > 3 > income Statement > eps

-0.5666964429589553

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

106453818

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-

Quarters > 3 > income Statement > currency_symbol

USD

Quarters > 3 > balance Sheet > cash

163635000

Quarters > 3 > balance Sheet > short Term Investments

208701000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

378183000

Quarters > 3 > balance Sheet > property Plant Equipment

83322000

Quarters > 3 > balance Sheet > total Assets

527700000

Quarters > 3 > balance Sheet > payables

-

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

64466000

Quarters > 3 > balance Sheet > equity

463234000

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-60327000

Quarters > 3 > cash Flow > depreciation

2361000

Quarters > 3 > cash Flow > change In Working Capital

-717000

Quarters > 3 > cash Flow > cash From Operations

-46942000

Quarters > 3 > cash Flow > capital Expenditures

309000

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

182849000

Quarters > 3 > cash Flow > net Change In Cash

98036000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.5666964429589553

Quarters > 3 > ratios > PB

0.004802939326992405

Quarters > 3 > ratios > ROE

-13.023007810307533

Quarters > 3 > ratios > ROA

-11.432063672541217

Quarters > 3 > ratios > FCF

-47251000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

42

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

0

Annuals > 0 > income Statement > cost Of Revenue

-

Annuals > 0 > income Statement > gross Profit

-

Annuals > 0 > income Statement > operating Expenses

273205000

Annuals > 0 > income Statement > operating Income

-273205000

Annuals > 0 > income Statement > interest Expense

1886000

Annuals > 0 > income Statement > pretax Income

-258746000

Annuals > 0 > income Statement > net Income

-258746000

Annuals > 0 > income Statement > eps

-2.4305938937765483

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

106453818

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

-

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

163635000

Annuals > 0 > balance Sheet > short Term Investments

208701000

Annuals > 0 > balance Sheet > receivables

-

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

378183000

Annuals > 0 > balance Sheet > property Plant Equipment

83322000

Annuals > 0 > balance Sheet > total Assets

527700000

Annuals > 0 > balance Sheet > payables

-

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

64466000

Annuals > 0 > balance Sheet > equity

463234000

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-258746000

Annuals > 0 > cash Flow > depreciation

9375000

Annuals > 0 > cash Flow > change In Working Capital

1919000

Annuals > 0 > cash Flow > cash From Operations

-209724000

Annuals > 0 > cash Flow > capital Expenditures

5862000

Annuals > 0 > cash Flow > cash From Investing

-

Annuals > 0 > cash Flow > cash From Financing

185739000

Annuals > 0 > cash Flow > net Change In Cash

107721000

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-2.4305938937765483

Annuals > 0 > ratios > PB

0.0033321827866693724

Annuals > 0 > ratios > ROE

-55.85643540845447

Annuals > 0 > ratios > ROA

-49.03278377866212

Annuals > 0 > ratios > FCF

-215586000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

33

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

-

Annuals > 1 > income Statement > gross Profit

-

Annuals > 1 > income Statement > operating Expenses

259659000

Annuals > 1 > income Statement > operating Income

-259659000

Annuals > 1 > income Statement > interest Expense

1875000

Annuals > 1 > income Statement > pretax Income

-245595000

Annuals > 1 > income Statement > net Income

-245595000

Annuals > 1 > income Statement > eps

-2.7203016512644727

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

90282267

Annuals > 1 > income Statement > income Tax Expense

-

Annuals > 1 > income Statement > EBITDA

-

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

-

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

55904000

Annuals > 1 > balance Sheet > short Term Investments

317271000

Annuals > 1 > balance Sheet > receivables

-

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

378222000

Annuals > 1 > balance Sheet > property Plant Equipment

87590000

Annuals > 1 > balance Sheet > total Assets

566341000

Annuals > 1 > balance Sheet > payables

-

Annuals > 1 > balance Sheet > short Term Debt

-

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

73767000

Annuals > 1 > balance Sheet > equity

492574000

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-245595000

Annuals > 1 > cash Flow > depreciation

7098000

Annuals > 1 > cash Flow > change In Working Capital

13822000

Annuals > 1 > cash Flow > cash From Operations

-194916000

Annuals > 1 > cash Flow > capital Expenditures

16472000

Annuals > 1 > cash Flow > cash From Investing

-

Annuals > 1 > cash Flow > cash From Financing

208401000

Annuals > 1 > cash Flow > net Change In Cash

-84581000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-2.7203016512644727

Annuals > 1 > ratios > PB

0.0026576572687555576

Annuals > 1 > ratios > ROE

-49.85951349441911

Annuals > 1 > ratios > ROA

-43.36521636258014

Annuals > 1 > ratios > FCF

-211388000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

33

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

0

Annuals > 2 > income Statement > cost Of Revenue

-

Annuals > 2 > income Statement > gross Profit

-

Annuals > 2 > income Statement > operating Expenses

223843000

Annuals > 2 > income Statement > operating Income

-223843000

Annuals > 2 > income Statement > interest Expense

1909000

Annuals > 2 > income Statement > pretax Income

-221863000

Annuals > 2 > income Statement > net Income

-221863000

Annuals > 2 > income Statement > eps

-2.8041067006690445

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

79120741

Annuals > 2 > income Statement > income Tax Expense

-

Annuals > 2 > income Statement > EBITDA

-213688000

Annuals > 2 > income Statement > operating Margin

-

Annuals > 2 > income Statement > total Other Income Expense Net

-

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

140517000

Annuals > 2 > balance Sheet > short Term Investments

215877000

Annuals > 2 > balance Sheet > receivables

-

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

364060000

Annuals > 2 > balance Sheet > property Plant Equipment

77645000

Annuals > 2 > balance Sheet > total Assets

551807000

Annuals > 2 > balance Sheet > payables

-

Annuals > 2 > balance Sheet > short Term Debt

-

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

62121000

Annuals > 2 > balance Sheet > equity

489686000

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-221863000

Annuals > 2 > cash Flow > depreciation

6266000

Annuals > 2 > cash Flow > change In Working Capital

6076000

Annuals > 2 > cash Flow > cash From Operations

-178142000

Annuals > 2 > cash Flow > capital Expenditures

8619000

Annuals > 2 > cash Flow > cash From Investing

-

Annuals > 2 > cash Flow > cash From Financing

155288000

Annuals > 2 > cash Flow > net Change In Cash

-92180000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-2.8041067006690445

Annuals > 2 > ratios > PB

0.0023428293733126944

Annuals > 2 > ratios > ROE

-45.30719685676127

Annuals > 2 > ratios > ROA

-40.20663021672433

Annuals > 2 > ratios > FCF

-186761000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-

Annuals > 2 > health Score

33

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

0

Annuals > 3 > income Statement > cost Of Revenue

-

Annuals > 3 > income Statement > gross Profit

-

Annuals > 3 > income Statement > operating Expenses

166248000

Annuals > 3 > income Statement > operating Income

-166248000

Annuals > 3 > income Statement > interest Expense

5889000

Annuals > 3 > income Statement > pretax Income

-169069000

Annuals > 3 > income Statement > net Income

-169069000

Annuals > 3 > income Statement > eps

-2.6209855041297083

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

64505889

Annuals > 3 > income Statement > income Tax Expense

-

Annuals > 3 > income Statement > EBITDA

-163180000

Annuals > 3 > income Statement > operating Margin

-

Annuals > 3 > income Statement > total Other Income Expense Net

-

Annuals > 3 > income Statement > currency_symbol

USD

Annuals > 3 > balance Sheet > cash

232694000

Annuals > 3 > balance Sheet > short Term Investments

156046000

Annuals > 3 > balance Sheet > receivables

-

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

392059000

Annuals > 3 > balance Sheet > property Plant Equipment

72348000

Annuals > 3 > balance Sheet > total Assets

497020000

Annuals > 3 > balance Sheet > payables

-

Annuals > 3 > balance Sheet > short Term Debt

-

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

42296000

Annuals > 3 > balance Sheet > equity

454724000

Annuals > 3 > balance Sheet > currency_symbol

USD

Annuals > 3 > cash Flow > net Income

-169069000

Annuals > 3 > cash Flow > depreciation

5373000

Annuals > 3 > cash Flow > change In Working Capital

-3386000

Annuals > 3 > cash Flow > cash From Operations

-121163000

Annuals > 3 > cash Flow > capital Expenditures

7715000

Annuals > 3 > cash Flow > cash From Investing

-

Annuals > 3 > cash Flow > cash From Financing

37681000

Annuals > 3 > cash Flow > net Change In Cash

-64629000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-2.6209855041297083

Annuals > 3 > ratios > PB

0.002056929897036444

Annuals > 3 > ratios > ROE

-37.1805754699554

Annuals > 3 > ratios > ROA

-34.01653856987647

Annuals > 3 > ratios > FCF

-128878000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-

Annuals > 3 > health Score

33

Valuation > metrics > PE

-0.4651384455491231

Valuation > metrics > PB

0.007210022790584979

Valuation > final Score

70

Valuation > verdict

99.3% Undervalued

Profitability > metrics > ROE

-16.04621432146626

Profitability > metrics > ROA

-22.10646521433591

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.17331645779468166

Risk > metrics > Interest Coverage

-110.82241014799155

Risk > final Score

-383

Risk > verdict

High

Liquidity > final Score

50

Liquidity > verdict

Weak

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

-512

Prev Risks > 1

-486

Prev Risks > 2

-470

Prev Liquidities > 0

50

Prev Liquidities > 1

50

Prev Liquidities > 2

50

Updated At

2026-01-20T22:28:04.885Z